PMS29 - SECUKINUMAB VERSUS ADALIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS- A COST PER RESPONDER ANALYSIS AMONG 52 WEEKS FROM A TUNISIAN PERSPECTIVE.
Abstract
Authors
S. Yahiaoui G. Ramakrishna J. Toumi J. Burke A. Kooli
S. Yahiaoui G. Ramakrishna J. Toumi J. Burke A. Kooli
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now